These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 29791202

  • 1. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
    Ni T, Shang XS, Wang WT, Hu XX, Zeng MS, Rao SX.
    Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
    [Abstract] [Full Text] [Related]

  • 2. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.
    Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI.
    Eur Radiol; 2016 Jun; 26(6):1808-17. PubMed ID: 26373763
    [Abstract] [Full Text] [Related]

  • 3. Distinguishing intrahepatic mass-forming biliary carcinomas from hepatocellular carcinoma by computed tomography and magnetic resonance imaging using the Bayesian method: a bi-center study.
    Ichikawa S, Isoda H, Shimizu T, Tamada D, Taura K, Togashi K, Onishi H, Motosugi U.
    Eur Radiol; 2020 Nov; 30(11):5992-6002. PubMed ID: 32500195
    [Abstract] [Full Text] [Related]

  • 4. A multi-center diagnostic system for intrahepatic mass-forming cholangiocarcinoma based on preoperative MRI and clinical features.
    Sheng R, Zhang Y, Wang H, Zhang W, Jin K, Sun W, Dai Y, Zhou J, Zeng M.
    Eur Radiol; 2024 Jan; 34(1):548-559. PubMed ID: 37552257
    [Abstract] [Full Text] [Related]

  • 5. Value of perfusion parameters histogram analysis of triphasic CT in differentiating intrahepatic mass forming cholangiocarcinoma from hepatocellular carcinoma.
    Zhao F, Pang G, Li X, Yang S, Zhong H.
    Sci Rep; 2021 Nov 30; 11(1):23163. PubMed ID: 34848818
    [Abstract] [Full Text] [Related]

  • 6. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
    Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K.
    Cancer Imaging; 2018 Feb 27; 18(1):8. PubMed ID: 29486800
    [Abstract] [Full Text] [Related]

  • 7. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
    Zheng W, Huang H, She D, Xiong M, Chen X, Lin X, Cao D.
    Abdom Radiol (NY); 2022 Mar 27; 47(3):957-968. PubMed ID: 34964069
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.
    Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK.
    J Magn Reson Imaging; 2016 Nov 27; 44(5):1330-1338. PubMed ID: 27087012
    [Abstract] [Full Text] [Related]

  • 9. Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
    Zhao YJ, Chen WX, Wu DS, Zhang WY, Zheng LR.
    Abdom Radiol (NY); 2016 May 27; 41(5):978-89. PubMed ID: 27193795
    [Abstract] [Full Text] [Related]

  • 10. Can contrast enhanced ultrasound differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma?
    Huang JY, Li JW, Ling WW, Li T, Luo Y, Liu JB, Lu Q.
    World J Gastroenterol; 2020 Jul 21; 26(27):3938-3951. PubMed ID: 32774068
    [Abstract] [Full Text] [Related]

  • 11. LI-RADS-CEUS - Proposal for a Contrast-Enhanced Ultrasound Algorithm for the Diagnosis of Hepatocellular Carcinoma in High-Risk Populations.
    Schellhaas B, Wildner D, Pfeifer L, Goertz RS, Hagel A, Neurath MF, Strobel D.
    Ultraschall Med; 2016 Dec 21; 37(6):627-634. PubMed ID: 27486793
    [Abstract] [Full Text] [Related]

  • 12. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
    Park HJ, Kim YK, Park MJ, Lee WJ.
    Abdom Imaging; 2013 Aug 21; 38(4):793-801. PubMed ID: 22829097
    [Abstract] [Full Text] [Related]

  • 13. Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.
    Park HJ, Jang KM, Kang TW, Song KD, Kim SH, Kim YK, Cha DI, Kim J, Goo J.
    Eur Radiol; 2016 Sep 21; 26(9):3102-11. PubMed ID: 26634931
    [Abstract] [Full Text] [Related]

  • 14. Differentiation between cholangiocarcinoma and hepatocellular carcinoma with target sign on diffusion-weighted imaging and hepatobiliary phase gadoxetic acid-enhanced MR imaging: Classification tree analysis applying capsule and septum.
    Min JH, Kim YK, Choi SY, Jeong WK, Lee WJ, Ha SY, Ahn S, Ahn HS.
    Eur J Radiol; 2017 Jul 21; 92():1-10. PubMed ID: 28624005
    [Abstract] [Full Text] [Related]

  • 15. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
    Horvat N, Nikolovski I, Long N, Gerst S, Zheng J, Pak LM, Simpson A, Zheng J, Capanu M, Jarnagin WR, Mannelli L, Do RKG.
    Abdom Radiol (NY); 2018 Jan 21; 43(1):169-178. PubMed ID: 28765978
    [Abstract] [Full Text] [Related]

  • 16. Small Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma in Cirrhotic Livers May Share Similar Enhancement Patterns at Multiphase Dynamic MR Imaging.
    Huang B, Wu L, Lu XY, Xu F, Liu CF, Shen WF, Jia NY, Cheng HY, Yang YF, Shen F.
    Radiology; 2016 Oct 21; 281(1):150-7. PubMed ID: 27077381
    [Abstract] [Full Text] [Related]

  • 17. Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma.
    Shin SK, Choi DJ, Kim JH, Kim YS, Kwon OS.
    Medicine (Baltimore); 2018 Oct 21; 97(41):e12781. PubMed ID: 30313099
    [Abstract] [Full Text] [Related]

  • 18. Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound.
    Chen LD, Ruan SM, Liang JY, Yang Z, Shen SL, Huang Y, Li W, Wang Z, Xie XY, Lu MD, Kuang M, Wang W.
    World J Gastroenterol; 2018 Sep 07; 24(33):3786-3798. PubMed ID: 30197484
    [Abstract] [Full Text] [Related]

  • 19. Optimizing CT and MRI criteria for differentiating intrahepatic mass-forming cholangiocarcinoma and hepatocellular carcinoma.
    Wu H, Liang Y, Wang Z, Tan C, Yang R, Wei X, Jiang X.
    Acta Radiol; 2023 Mar 07; 64(3):926-935. PubMed ID: 35898164
    [Abstract] [Full Text] [Related]

  • 20. A convenient scoring system to distinguish intrahepatic mass-forming cholangiocarcinoma from solitary colorectal liver metastasis based on magnetic resonance imaging features.
    Shen K, Mo W, Wang X, Shi D, Qian W, Sun J, Yu R.
    Eur Radiol; 2023 Dec 07; 33(12):8986-8998. PubMed ID: 37392232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.